Vaccines

Pfizer Stock Rises as Company Unveils Timeline for Coronavirus Vaccine

Text size Daniel Acker/Bloomberg Shares of the big pharma firm Pfizer continue to climb a day after the company unveiled promising, and detailed, data on … Read more

Indonesia seeking its own COVID-19 vaccine amid worry about access

(Reuters) – Indonesia is working to produce its own COVID-19 vaccine next year, amid growing anxiety that developing countries could have difficulty getting access to … Read more

New FDA Guidance May Not Allow Covid-19 Vaccine This Year, Analyst Says

Text size The Food and Drug Administration’s new guidance document for developers of Covid-19 vaccines doesn’t spell out a timeline. SVB Leerink analyst Geoffrey Porges … Read more

Pfizer Offers Hope, and Details, on Potential Coronavirus Vaccine

Text size Drew Angerer/Getty Images Promising and detailed new data from the drug giant Pfizer and its German biotech partner BioNTech on an experimental Covid-19 … Read more

Coronavirus Vaccine Candidate from Pfizer, BioNTech Produces Positive Results in Early Study

Researchers said an experimental coronavirus vaccine from Pfizer Inc. and partner BioNTech SE showed promising signs of working in an early-stage study. Healthy adult volunteers … Read more

After months of speculation, investors get excited about Pfizer, BioNTech’s coronavirus vaccine candidate

The path to a COVID-19 vaccine has started to come into view this week, following the stock-moving disclosures of early-stage clinical data for two vaccine … Read more

Oxford COVID-19 vaccine developers encouraged by immune response but cautious on timeframe

LONDON (Reuters) – A leading scientist behind the University of Oxford’s potential COVID-19 vaccine said on Wednesday the team has seen the right sort of … Read more

BioNTech and Pfizer’s COVID-19 vaccine shows potential in human trial

FRANKFURT (Reuters) – A COVID-19 vaccine developed by German biotech firm BioNTech and U.S. pharmaceutical giant Pfizer has shown potential and was found to be … Read more